The eighth edition of the AJCC Cancer Staging System is focused on the individual treatment and prognostic factors of CRC based on molecular biomarkers, such as BRAF, KRAS, and NRAS that are associated with chromosomal instability, mismatch repair, and microsatellite instability [17]. This evidence concerns the gene NRAS and colorectal carcinoma.